Article Text

Download PDFPDF
Launch of the BASHH guideline for the management of M. genitalium in adults
  1. Suneeta Soni1,
  2. Paddy J Horner2,3
  1. 1 Lawson Unit, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
  2. 2 School of Social and Community Medicine, University of Bristol, Bristol, UK
  3. 3 Bristol Sexual Health Centre, University Hospitals Bristol NHS Foundation Trust, Bristol, UK
  1. Correspondence to Dr Suneeta Soni, Lawson Unit, Brighton and Sussex University Hospitals NHS Trust, Brighton BN25BE, UK; suneetasoni{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The consultation version of the first BASHH guideline for the management of Mycoplasma genitalium was launched on 11 July.1 This coincided with a 1-day M. genitalium educational event in London, supported by Hologic and attended by 150 delegates from all over the UK. The morning sessions covered basic science and relevant clinical data, and Michelle Cole from Public Health England (PHE) talked about the mechanisms of antimicrobial resistance (AMR) in M. genitalium. In the afternoon we heard about diagnostic testing and the challenges of implementation, and Gwenda Hughes presented the arguments against screening for M. genitalium, recommending that testing should be directed at individuals with relevant symptoms and their current sexual partners. The day ended with a lively interactive session with four complex case presentations and expert panel and audience discussion.

While feedback from the day was excellent, the concerns around funding and setting up M. genitalium testing were quite apparent. The publication of the National Institute for Health and …

View Full Text


  • Handling editor Jackie Cassell

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.